Skip to main content

XRX

Stock

XRX

Stock
Information Technology
Information Technology Services

Performance overview

XRX Price
Price Chart

Forward-looking statistics

Beta
1.18
Risk
49.73%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

xerox is helping change the way the world works. by applying our expertise in imaging, business process, analytics, automation and user-centric insights, we engineer the flow of work to provide greater productivity, efficiency and personalization. we conduct business in 180 countries, and our more than 130,000 employees create meaningful innovations and provide business process services,printing equipment, software and solutions that make a real difference for our clients – and their customers.

Company info

SectorInformation Technology
IndustryInformation Technology Services
Employees35K
Market cap$1.8B

Fundamentals

Enterprise value$4.1B
Revenue$6.2B
Revenue per employee
Profit margin-21.02%
Debt to equity273.85

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$10.56
Dividend per share$0.10
Revenue per share$49.60
Avg trading volume (30 day)$17M
Avg trading volume (10 day)$13M
Put-call ratio

Macro factor sensitivity

Growth+1.0
Credit+5.6
Liquidity-0.1
Inflation-2.1
Commodities-0.7
Interest Rates-2.9

Valuation

Dividend yield1.85%
PEG Ratio4.65
Price to sales0.12
P/E Ratio4.65
Enterprise Value to Revenue0.66
Price to book0.68

Upcoming events

Next earnings dayMay 1, 2025
Next dividend day
Ex. dividend dayJune 30, 2025

News

Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $5.72, marking a +2.24% move from the previous day.

Zacks Investment Research (July 10, 2025)
What's Happening With RXRX Stock?

Recursion Pharmaceuticals (NASDAQ:RXRX) has experienced notable share price fluctuations in 2025, falling 27% year-to-date and trading over 55% beneath its 52-week high of $12. In spite of this underperformance, the clinical-stage TechBio firm continues to attract interest for its innovative approach to drug discovery driven by AI and machine learning.

Forbes (July 8, 2025)
Ross Stores, Deckers Outdoor, Xerox Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Friday.

Benzinga (May 23, 2025)
Xerox Holdings Reports Q1 Loss, Revenues Miss Estimates

XRX's first-quarter 2025 revenues decrease year over year.

Zacks Investment Research (May 2, 2025)
5 Small Caps Yielding 9%-15%: Hidden Values Or Overlooked Trash?

The index huggers are, rightfully, fretting about the only position they own, the S&P 500, which is heavy on Nvidia (NVDA). The soon-to-be-fallen angel is the third largest component of the index at 6.3%.

Forbes (September 8, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free